Jazz Pharmaceuticals (JAZZ) Tops Q1 EPS by 2c; Boosts FY11 EPS Outlook
Tweet Send to a Friend
Jazz Pharmaceuticals (NASDAQ: JAZZ) reported Q1 EPS of $0.59, $0.02 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
